ERBB2 and breast carcinoma: In order to evaluate the benefits of well-based RPPA in HER-2 assessment, we extracted protein from 76 human breast cancer FFPE tissues and subsequently we performed a prospective study comparing HER-2 determination with IHC and well-based RPPA.